Cohance Lifesciences Makes Q3FY26 Conference Call Recording Available
Cohance Lifesciences Limited has uploaded the audio recording of its conference call for Q3FY26 and nine months ended December 31, 2025, on its website. The call was held on February 12, 2026, and the recording is now accessible to stakeholders. This disclosure complies with SEBI regulations and ensures transparency in corporate communications.
*this image is generated using AI for illustrative purposes only.
Cohance lifesciences Limited has announced the availability of its quarterly conference call recording for the quarter and nine months ended December 31, 2025. The company has fulfilled its regulatory disclosure obligations by making the audio recording accessible to stakeholders and the public.
Conference Call Details
The conference call was conducted on Thursday, February 12, 2026, following the company's earlier intimation dated January 22, 2026. The audio recording has been uploaded on the company's official website and is available for download and review by interested parties.
| Parameter: | Details |
|---|---|
| Call Date: | February 12, 2026 |
| Period Covered: | Q3FY26 and nine months ended December 31, 2025 |
| Website Link: | https://www.cohance.com/wp-content/uploads/2026/02/10039581.mp3 |
| Prior Intimation: | January 22, 2026 |
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This ensures that the company maintains transparency with its stakeholders and complies with mandatory disclosure requirements.
Corporate Information
The communication was signed by Himanshu Agarwal, Whole-time Director and Chief Financial Officer, bearing DIN: 06672915. The company, formerly known as Suven Pharmaceuticals Limited, trades on both BSE and NSE with scrip code 543064 and symbol COHANCE respectively.
The availability of the conference call recording allows investors, analysts, and other stakeholders to access detailed discussions about the company's performance for the specified period, ensuring continued transparency in corporate communications.
Historical Stock Returns for Cohance Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -10.02% | -11.55% | -31.00% | -66.81% | -69.89% | -35.64% |
16
